Do Quality-of-Life Measures Represent Patient Outcomes in Stroke Trials?

Affiliations

¹ From the Schools of Cardiovascular and Metabolic Health (T.J.Q.) and Psychology and Neuroscience (K.W.M.), University of Glasgow, Scotland, United Kingdom.
² From the Schools of Cardiovascular and Metabolic Health (T.J.Q.) and Psychology and Neuroscience (K.W.M.), University of Glasgow, Scotland, United Kingdom. keith.muir@glasgow.ac.uk.

Free article

Editorial

Terence J Quinn et al. Neurology. 2023.

Free article

. 2023 Mar 28;100(13):597-598.

doi: 10.1212/WNL.0000000000206840. Epub 2023 Jan 11.

¹ From the Schools of Cardiovascular and Metabolic Health (T.J.Q.) and Psychology and Neuroscience (K.W.M.), University of Glasgow, Scotland, United Kingdom.
² From the Schools of Cardiovascular and Metabolic Health (T.J.Q.) and Psychology and Neuroscience (K.W.M.), University of Glasgow, Scotland, United Kingdom. keith.muir@glasgow.ac.uk.

No abstract available

Comment on

Disentangling the Association Between Neurologic Deficits, Patient-Reported Impairments, and Quality of Life After Ischemic Stroke.
van der Ende NAM, den Hartog SJ, Broderick JP, Khatri P, Visser-Meily JMA, van Leeuwen N, Lingsma HF, Roozenbeek B, Dippel DWJ; IMS III Investigators. van der Ende NAM, et al. Neurology. 2023 Mar 28;100(13):e1321-e1328. doi: 10.1212/WNL.0000000000206747. Epub 2023 Jan 4. Neurology. 2023. PMID: 36599699 Free PMC article. Clinical Trial.